Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer.

MLA

Kanlikilicer, Pinar, et al. “Exosomal MiRNA Confers Chemo Resistance via Targeting Cav1/p-Gp/M2-Type Macrophage Axis in Ovarian Cancer.” EBioMedicine, vol. 38, Dec. 2018, pp. 100–12. EBSCOhost, https://doi.org/10.1016/j.ebiom.2018.11.004.

APA

Kanlikilicer, P., Bayraktar, R., Denizli, M., Rashed, M. H., Ivan, C., Aslan, B., Mitra, R., Karagoz, K., Bayraktar, E., Zhang, X., Rodriguez-Aguayo, C., El-Arabey, A. A., Kahraman, N., Baydogan, S., Ozkayar, O., Gatza, M. L., Ozpolat, B., Calin, G. A., Sood, A. K., & Lopez-Berestein, G. (2018). Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer. EBioMedicine, 38, 100–112. https://doi.org/10.1016/j.ebiom.2018.11.004

Chicago

Kanlikilicer, Pinar, Recep Bayraktar, Merve Denizli, Mohammed H Rashed, Cristina Ivan, Burcu Aslan, Rahul Mitra, et al. 2018. “Exosomal MiRNA Confers Chemo Resistance via Targeting Cav1/p-Gp/M2-Type Macrophage Axis in Ovarian Cancer.” EBioMedicine 38 (December): 100–112. doi:10.1016/j.ebiom.2018.11.004.